Nuvance Health expands at-home cognitive care program to primary care practices

What is mild cognitive impairment?

MCI is an early stage of memory loss or other cognition problems, such as language and thinking difficulties. According to the Alzheimer’s Association, 12% to 18% of people aged 60 and older have MCI in the United States. 

Risk factors for mild cognitive impairment

The risk of MCI increases with age. Other risk factors include:

• Diabetes

• Depression

• Heart disease

• High blood pressure

• Stroke

Related content: Do heartburn meds increase the risk of cognitive decline?

Signs of mild cognitive impairment

Signs of MCI include regular forgetfulness, losing things often and having trouble finding your words. If you or a loved one are consistently experiencing these signs, see your primary care provider for an assessment.

Find a primary care provider near me.

MCI is not a form of dementia. However, the Alzheimer’s Association estimates that 10% to 15% of people with MCI eventually develop dementia every year.

What is early-stage dementia?

Early-stage dementia refers to the initial phase of cognitive decline where an individual begins to experience noticeable and persistent changes in memory, thinking and reasoning abilities. People with MCI and early-stage dementia can usually function independently. The main difference is more symptoms are usually present with early-stage dementia.

Common signs of early-stage dementia include:

• Memory loss: Frequent forgetfulness, especially of recent events or newly learned information.

• Difficulty with complex tasks: Trouble planning, organizing or completing routine tasks, such as daily household chores. 

• Confusion with time or place: Occasional disorientation, such as losing track of dates or becoming confused in familiar settings. 

• Changes in mood or behavior: Subtle shifts in personality or mood, including increased irritability, anxiety or apathy.

Early-stage dementia is often a precursor to more advanced stages of dementia, such as Alzheimer’s disease. Recognizing these early signs is crucial for seeking timely intervention, which can help manage symptoms and potentially slow the progression of the disease.

Why expand remote care for mild cognitive impairment and early-stage dementia to primary care?

Expanding Neuroglee Connect™ into primary care practices stems from the critical role providers play in the overall health management of individuals. Primary care providers help people manage diabetes, heart disease and high blood pressure, which can all affect cognitive health. Primary care providers are often the first to assess cognitive health as part of the comprehensive care they offer.

By integrating Neuroglee Connect™ into primary care, Nuvance Health aims to:

• Help more people by identifying cognitive concerns early, which is crucial for effective intervention.

• Intervene early, which may improve cognitive function and slow the condition’s progression.

How will primary care patients use Neuroglee Connect™ for mild cognitive impairment and early-stage dementia?

Nuvance Health Medical Practice primary care providers will offer the Neuroglee Connect™ program to patients diagnosed with MCI and early-stage dementia. Patients and caregivers will receive a mobile device to access the program.

“It’s like a medical mental games app and many more brain-stimulating and wellness activities with physician supervision and tracking,” said Dr. Alex Mosteanu, regional medical director of Nuvance Health Medical Practice Primary Care East. “It’s like sending your brain to the gym.”  

The importance of early intervention for MCI and early-stage dementia

While MCI and early-stage dementia are not curable, early detection can help slow the progression of symptoms.

• Slowing dementia progression: Early intervention with cognitive exercises and health education can delay the progression of dementia and affect patient outcomes and the impact on loved ones.

• Improving daily functioning: By engaging in regular cognitive training, people can improve their daily functioning and maintain their independence as much as possible.

“Evidence-based brain exercises strengthen cognitive function and provide a sense of accomplishment and control over their health,” said Dr. Paul Wright, senior vice president and system chair of the Nuvance Health Neuroscience Institute.

Learn more about cognitive care at the Nuvance Health Neuroscience Institute.

Remote cognitive care impact on patients and caregivers

The expansion of Neuroglee Connect™ should have a meaningful impact on primary care patients with MCI and early-stage dementia and their caregivers based on the following outcomes:

• Patient experience: Previous use in neurology practices has shown high levels of satisfaction among patients and caregivers who appreciate the structured cognitive support and care coordination.

• Enhanced cognitive abilities: Regular access to brain exercises and monitoring helps people improve their cognitive function through engaging activities.

• Support for caregivers: The program provides tools and strategies to assist their loved ones.

Helping people with remote cognitive care for MCI and early-stage dementia